SCHEMBL2286483

SCHEMBL2286483

COC(=O)C(CNC(=O)OC(C)(C)C)c1cccc2ncc(OC)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 4/20 0.39
MTNR1A P48039 3/20 0.39
KDM4E B2RXH2 4/20 0.37
TDP1 Q9NUW8 1/20 0.37
BCHE P06276 1/20 0.36
SYK P43405 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GFER P55789 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PCSK9 Q8NBP7 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
BRD4 O60885 1/20 0.34
NQO2 P16083 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
CKS1B P61024 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1711909 0.88 KDM4E (0.38) MTNR1BMTNR1AKDM4ETDP1BCHE
SCHEMBL1712711 0.88 KDM4E (0.38) MTNR1BMTNR1AKDM4ETDP1BCHE
SCHEMBL1711958 0.86 MTNR1B (0.39) MTNR1BMTNR1AKDM4ETDP1BCHE
SCHEMBL1712209 0.81 KMT2A (0.38) MTNR1BMTNR1AKDM4EMEN1GAA
SCHEMBL3818896 0.80 CPB2 (0.34) MTNR1BMTNR1AKDM4ETDP1BCHE
SCHEMBL3888157 0.80 ACACB (0.34) MTNR1BMTNR1AKDM4ETDP1BCHE
SCHEMBL1712708 0.80 KDM4E (0.39) MTNR1BMTNR1AKDM4ETDP1HDAC4
SCHEMBL1711908 0.80 KDM4E (0.39) MTNR1BMTNR1AKDM4ETDP1HDAC4
SCHEMBL31724166 0.76 DRD2 (0.47) MTNR1BMTNR1ASYK
SCHEMBL21807073 0.76 MTNR1A (0.39) MTNR1BMTNR1AKDM4ETDP1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9822114-B2 Tricyclic oxazolidinone antibiotic compounds IDORSIA PHARMACEUTICALS LTD (CH) 2017-11-21 US disclosed
US-20160237088-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS IDORSIA PHARMACEUTICALS LTD (CH) 2016-08-18 US disclosed
US-9346804-B2 Tricyclic oxazolidinone antibiotic compounds ACTELION PHARMACEUTICALS LTD. (CH) 2016-05-24 US disclosed
EP-2344495-B1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2014-12-31 EP disclosed
US-20140142093-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD. (CH) 2014-05-22 US disclosed
US-8618092-B2 Tricyclic oxazolidinone antibiotic compounds ACTELION PHARMACEUTICALS LTD. (CH) 2013-12-31 US disclosed
US-20110195961-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD. (CH) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195961-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS HRH3, OXA1L, HRH1 MTNR1B 670/4885MTNR1A 987/4885KDM4E 3061/4885
US-20160237088-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS H1-3, HRH3, HRH4 MTNR1B 860/4885MTNR1A 1089/4885KDM4E 2290/4885
US-20140142093-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS OXA1L, H1-3, NGLY1 MTNR1B 897/4885MTNR1A 1119/4885KDM4E 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.